Franchise opportunities compared

    Amerisourcebergen Drug vs MATCO

    Reviewed figures from each brand's Franchise Disclosure Document (FDD), side by side. Each figure carries its FDD year and page. This is not a ranking or recommendation, and the two FDDs may cover different years and location groups.

    Initial investment · Item 7

    Amerisourcebergen Drug

    $5,000 – $12,000

    2026 FDD · Item 7 · PDF p. 29

    MATCO

    $104,374 – $376,241

    2026 FDD · Item 7 · PDF p. 1

    Initial franchise fee · Item 5

    Amerisourcebergen Drug

    Not available

    MATCO

    $10,000

    2026 FDD · Item 5 · PDF p. 26

    Royalty · Item 6

    Amerisourcebergen Drug

    $599

    2026 FDD · Item 6 · PDF p. 23

    MATCO

    Not available

    Before you compare

    • Both sets of figures come from 2026 FDDs.
    • Only MATCO has reviewed Item 19 figures here.

    Financial commitment

    Estimated initial investment (Item 7)

    Amerisourcebergen Drug

    $5,000 – $12,000
    xisting pharmacy with no GNP Private Label product on your shelves we estimate an investment of — 5000
    2026 FDD · Item 7 · PDF p. 29

    MATCO

    $104,374 – $376,241
    Total initial investment for a Matco Distributorship
    2026 FDD · Item 7 · PDF p. 1
    Standard initial franchise fee (Item 5)

    Amerisourcebergen Drug

    Not available
    No single standard fee identified

    MATCO

    $10,000
    2026 FDD · Item 5 · PDF p. 26
    Royalty (Item 6)

    Amerisourcebergen Drug

    $599
    ITEM 6 OTHER FEES Type of Fee Amount Due Date Remarks, Definitions and Caveats GNP Premier Fee — 599
    2026 FDD · Item 6 · PDF p. 23

    MATCO

    Not available
    No reviewed royalty record
    Brand / advertising fund (Item 6)

    Amerisourcebergen Drug

    Not available
    No reviewed brand or advertising fund fee

    MATCO

    Not available
    No reviewed brand or advertising fund fee

    System scale & health

    Total outlets (Item 20)

    Amerisourcebergen Drug

    2,204
    Outlets at end of 2025
    2026 FDD · Item 20 · PDF p. 55

    MATCO

    1,741
    Outlets at end of 2025
    2025 FDD · Item 20 · PDF p. 85
    Net outlet change (Item 20)

    Amerisourcebergen Drug

    −94
    Calculated: 2,298 at end of 2023 → 2,204 at end of 2025

    MATCO

    −74
    Calculated: 1,815 at end of 2022 → 1,741 at end of 2025
    Outlet exits (Item 20)

    Amerisourcebergen Drug

    Not available
    No complete exit records for a year

    MATCO

    Not available
    No complete exit records for a year
    Franchising since (Item 1)

    Amerisourcebergen Drug

    Not available
    Not in reviewed records

    MATCO

    Not available
    Not in reviewed records
    Franchisor founded (Item 1)

    Amerisourcebergen Drug

    Not available
    Not in reviewed records

    MATCO

    Not available
    Not in reviewed records

    Financial performance (Item 19), by location group

    Amerisourcebergen Drug

    No reviewed Item 19 figures

    MATCO
    Locations counted not stated in the reviewed record — All Reporting Distributorships, middle 1/3
    $485,873
    other Total Completed Business
    2026 FDD · Item 19 · PDF p. 82
    Locations counted not stated in the reviewed record — All Reporting Distributorships, top 1/3
    $765,946
    other Total Completed Business
    2026 FDD · Item 19 · PDF p. 82
    Locations counted not stated in the reviewed record — All Reporting Distributorships, bottom 1/3
    $298,304
    other Total Completed Business
    2026 FDD · Item 19 · PDF p. 82
    +1 more groups in the full report

    Item 19 groups are shown separately and never combined. Revenue or sales figures are not profit. Net outlet change and turnover are Franopolis calculations from the disclosed counts; turnover is a count-based rate, not a measure of owner earnings.

    Amerisourcebergen Drug vs MATCO: common questions

    Which costs less to open, Amerisourcebergen Drug or MATCO?
    Amerisourcebergen Drug: $5,000 – $12,000 (2026 FDD · Item 7 · PDF p. 29); MATCO: $104,374 – $376,241 (2026 FDD · Item 7 · PDF p. 1). These are each franchisor's Item 7 estimated initial investment. The low end of the disclosed estimate is lower for Amerisourcebergen Drug. Estimates are not quotes, and the FDD years may differ.
    Which has more locations, Amerisourcebergen Drug or MATCO?
    Amerisourcebergen Drug: 2,204 (2026 FDD · Item 20 · PDF p. 55); MATCO: 1,741 (2025 FDD · Item 20 · PDF p. 85). Total outlets from Item 20. Outlet counts do not indicate territory availability or franchisee results.
    Do Amerisourcebergen Drug and MATCO disclose financial performance (Item 19)?
    Amerisourcebergen Drug has no reviewed Item 19 figures on file; MATCO has reviewed Item 19 figures for 4 location groups. Different location groups are not directly comparable, and revenue is not profit.

    Answers restate the reviewed figures above. Not a ranking or recommendation.

    How Franopolis reviews FDD figures

    Keep researching